Robbins, Paul F.
National Cancer Institute · Center for Cancer Research
9 papers on CoChatORCID 0000-0002-1260-8123
Most cited papers
- Verified
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science
Immunotherapy and Immune ResponsesT-cell and B-cell Immunology
Cited by 2,823
- Verified
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Tran, E., Robbins, P. F., Lu, Y.-C., Prickett, T. D., Gartner, J. J., Jia, L., Pasetto, A., Zheng, Z., Ray, S., Groh, E. M., et al. (2016) · New England Journal of Medicine
Immunotherapy and Immune ResponsesCAR-T cell therapy research
Cited by 1,368
- Verified
Identification of essential genes for cancer immunotherapy
Patel, S. J., Sanjana, N. E., Kishton, R. J., Eidizadeh, A., Vodnala, S. K., Cam, M., Gartner, J. J., Jia, L., Steinberg, S. M., Yamamoto, T. N., et al. (2017) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 870
- Verified
Immunogenicity of somatic mutations in human gastrointestinal cancers
Tran, E., Ahmadzadeh, M., Lu, Y.-C., Gros, A., Turcotte, S., Robbins, P. F., Gartner, J. J., Zheng, Z., Li, Y. F., Ray, S., et al. (2015) · Science
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 729
- Verified
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., & Rosenberg, S. A. (1996) · The Journal of experimental medicine
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 550
- Verified
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations
Tran, E., Robbins, P. F., & Rosenberg, S. A. (2017) · Nature Immunology
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 443
- Verified
mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Cafri, G., Gartner, J. J., Zaks, T., Hopson, K., Levin, N., Paria, B. C., Parkhurst, M. R., Yossef, R., Lowery, F. J., Jafferji, M. S., et al. (2020) · Journal of Clinical Investigation
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 427
- Verified
A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers
Hanada, K.-I., Zhao, C., Gil-Hoyos, R., Gartner, J. J., Chow-Parmer, C., Lowery, F. J., Krishna, S., Prickett, T. D., Kivitz, S., Parkhurst, M. R., et al. (2022) · Cancer Cell
Cancer Immunotherapy and BiomarkersCAR-T cell therapy research
Cited by 200
- Verified
Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens
Wu, D., Yin, R., Chen, G., Ribeiro-Filho, H. V., Cheung, M., Robbins, P. F., Mariuzza, R. A., & Pierce, B. G. (2024) · Science Advances
vaccines and immunoinformatics approachesT-cell and B-cell Immunology
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free